Article
Author(s):
San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.
Daily Derm Times: April 1, 2025
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Challenges and Future Directions in Microbiome Engineering
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Optimizing Vitiligo Care: Key Expert Takeaways
Dermatology Conferences and Meetings Calendar: April 2025